Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy-Reference-Cited by-同舟云学术

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy

Published:2016-09 Issue:5 Volume:17 Page:384-390
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Ulivi Paola,Chiadini Elisa,Dazzi Claudio,Dubini Alessandra,Costantini Matteo,Medri Laura,Puccetti Maurizio,Capelli Laura,Calistri Daniele,Verlicchi Alberto,Gamboni Alessandro,Papi Maximilian,Mariotti Marita,De Luigi Nicoletta,Scarpi Emanuela,Bravaccini Sara,Turolla Gian Michele,Amadori Dino,Crinò Lucio,Delmonte Angelo

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Frequency of and variables associated with the EGFR mutation and its subtypes;Tanaka;Int J Cancer,2010

2. EGFR mutations in non–small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment;Marchetti;J Clin Oncol,2005

3. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

4. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non–small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial;Rosell;Lancet Oncol,2012

5. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials;Yang;Lancet Oncol,2015

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Clinical Features and Treatment Strategies in Advanced Lung Adenocarcinoma Patients With Acquired ALK Fusion After Resistance of EGFR-TKIs;2024-05-31

2. Synchronous Primary Lung Cancers Containing Discrete Driver Mutations in a Never-Smoker: Case Report;Case Reports in Oncology;2023-11-14

3. Clinical Challenge of Two Competing Targetable Mutations in Non-Small-Cell Lung Cancer: A Case Report;Diagnostics;2023-10-02

4. Oncogenèse pulmonaire et bases biologiques des traitements ciblés;Revue des Maladies Respiratoires Actualités;2023-10

5. Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer;Frontiers in Pharmacology;2023-08-29